Trial Profile
Prospective study of dihydrogalactitol (VAL-083) in patients with non small cell lung cancer
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs Dianhydrogalactitol (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Nov 2015 New trial record